17:07 , Jun 9, 2017 |  BioCentury  |  Finance

Pedaling to the clinic

With lead candidate BT-1718 expected to enter the clinic this year, Bicycle Therapeutics Ltd. has padded its coffers with a £40 million ($51.3 million) series B to expand its pipeline of bicyclic peptides for cancer....
16:26 , Jun 1, 2017 |  BC Extra  |  Financial News

Bicycle closes £40 million series B

Bicycle Therapeutics Ltd. (Cambridge, U.K.) raised £40 million ($51.3 million) in a series B round led by new investor Vertex Ventures HC. New investors Cambridge Innovation Capital and Longwood Fund also participated, as did existing...
07:00 , Oct 19, 2015 |  BioCentury  |  Finance

Funding cycles

After five years of drip feeding Bicycle Therapeutics Ltd. , the investor syndicate has installed new CEO Kevin Lee into a company that's fully funded to advance programs into the clinic. The VCs think the...